Ribosomal family protein Rps4x was associated with CD4+ T cell activation, and potentially served as a biomarker for the diagnosis and treatment of Alzheimer's Disease (Y. Wang et al., 2023). This evidence concerns the gene RPS4X and early-onset autosomal dominant Alzheimer disease.